- ScienceDaily
- 21/6/20 16:42
Researchers have found that certain commensal bacteria that reside in the human intestine produce compounds that inhibit SARS-CoV-2.
Researchers have found that certain commensal bacteria that reside in the human intestine produce compounds that inhibit SARS-CoV-2.
Researchers have optimized a new technique that will allow scientists to evaluate how potential inhibitors work on antibiotic-resistant bacteria. This technique, called native state mass spectrometry, provides a quick way for scientists to identify the best candidates for effective clinical drugs, particularly in cases where bacteria can no longer be treated with antibiotics alone.
Although two SARS-CoV-2 variants are associated with higher transmission, patients with these variants show no evidence of higher viral loads in their upper respiratory tracts compared to the control group, a new study found.